Overview
- 221 inspections across 179 sites are on record.
- 301 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-03-09.
At a glance
Inspections
221
Sites
179
Observations
301
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Virtual Scopics LLC | 9 Mar 2021 | Human Drugs | |
| Genovefa A Papanicolaou, MD | 27 Jan 2021 | Human Drugs | View 483 → |
| Matthew G. Davis, M.D. | 12 Nov 2020 | Biologics | |
| Robert S. Rosenson, M.D. | 29 Oct 2020 | Human Drugs | |
| Athenex, Inc. | 17 Sep 2020 | Human Drugs |
Sites inspected
Virtual Scopics LLCRochester, United States1 insp.
Genovefa A Papanicolaou, MDNew York, United States1 insp.
Matthew G. Davis, M.D.Rochester, United States1 insp.
Robert S. Rosenson, M.D.New York, United States1 insp.
Athenex, Inc.Buffalo, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Marlene L Davis6 shared
James D Bridges6 shared
Benton M Ketron4 shared
Marc S Neubauer4 shared
Omadevi Somai3 shared
Lauren E Blaser3 shared
Jeanette L Mcginnis3 shared
Johnna L Bleem2 shared
Joanne M Schlossin2 shared
Tara K Carmody2 shared
Full investigator report
Get the verbatim findings behind Karen L Kosar's 301 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site